157 related articles for article (PubMed ID: 38166710)
1. Enhanced renal clearance impacts levetiracetam concentrations in patients with traumatic brain injury with and without augmented renal clearance.
Cook AM; Hall K; Kolpek JH; Morbitzer KA; Jordan JD; Rhoney DH
BMC Neurol; 2024 Jan; 24(1):12. PubMed ID: 38166710
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain Injury.
Nelson NR; Morbitzer KA; Jordan JD; Rhoney DH
Neurocrit Care; 2019 Feb; 30(1):126-131. PubMed ID: 30051194
[TBL] [Abstract][Full Text] [Related]
3. Augmented renal clearance of vancomycin and levetiracetam in a traumatic brain injury patient.
Cook AM; Arora S; Davis J; Pittman T
Neurocrit Care; 2013 Oct; 19(2):210-4. PubMed ID: 23907742
[TBL] [Abstract][Full Text] [Related]
4. Population Pharmacokinetics of Levetiracetam in Patients with Traumatic Brain Injury and Subarachnoid Hemorrhage Exhibiting Augmented Renal Clearance.
Sime FB; Roberts JA; Jeffree RL; Pandey S; Adiraju S; Livermore A; Butler J; Parker SL; Wallis SC; Lipman J; Cotta MO
Clin Pharmacokinet; 2021 May; 60(5):655-664. PubMed ID: 33428169
[TBL] [Abstract][Full Text] [Related]
5. Incidence and determinats of augmented renal clearance in traumatic brain injury: A prospective observational study.
Campassi ML; Repetto FG; Banegas Litardo DM; Castor R; Gómez G; Tiseyra B; Flores L; Ramirez I; Maspoli D; Báez J; Boroni I; Bertola R; Estenssoro E; Dubin A
J Crit Care; 2022 Aug; 70():154065. PubMed ID: 35605338
[TBL] [Abstract][Full Text] [Related]
6. Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function.
Bilbao-Meseguer I; Barrasa H; Asín-Prieto E; Alarcia-Lacalle A; Rodríguez-Gascón A; Maynar J; Sánchez-Izquierdo JÁ; Balziskueta G; Griffith MS; Quilez Trasobares N; Solinís MÁ; Isla A
Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683983
[TBL] [Abstract][Full Text] [Related]
7. Creatinine Clearance in Acute Brain Injury: A Comparison of Methods.
Monteiro E; Fraga Pereira M; Barroso I; Dias CC; Czosnyka M; Paiva JA; Dias C
Neurocrit Care; 2023 Oct; 39(2):514-521. PubMed ID: 37016059
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam Prophylaxis for Post-traumatic Brain Injury Seizures is Ineffective: A Propensity Score Analysis.
Zangbar B; Khalil M; Gruessner A; Joseph B; Friese R; Kulvatunyou N; Wynne J; Latifi R; Rhee P; O'Keeffe T
World J Surg; 2016 Nov; 40(11):2667-2672. PubMed ID: 27307089
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Levetiracetam Dosing Strategies for Seizure Prophylaxis Following Traumatic Brain Injury.
Ohman K; Kram B; Schultheis J; Sigmon J; Kaleem S; Yang Z; Lee HJ; Vatsaas C; Komisarow J
Neurocrit Care; 2023 Apr; 38(2):345-355. PubMed ID: 36167949
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of Levetiracetam Seizure Prophylaxis in Severe Traumatic Brain Injury.
Harlan SS; Philpott CD; Keegan SP; Droege ME; Karve AS; Foreman B; Wakefield D; Mueller EW; Sangha K; Ngwenya LB; Courter JD; Desai P; Droege C
Ann Pharmacother; 2024 Jul; 58(7):705-714. PubMed ID: 37776163
[TBL] [Abstract][Full Text] [Related]
11. Use of Levetiracetam for Post-Traumatic Seizure Prophylaxis in Combat-Related Traumatic Brain Injury.
Atwood R; Walker P; Walper D; Elster E; Bradley M
Mil Med; 2023 Nov; 188(11-12):e3570-e3574. PubMed ID: 37256778
[TBL] [Abstract][Full Text] [Related]
12. Low-dose levetiracetam for seizure prophylaxis after traumatic brain injury.
Patanwala AE; Kurita A; Truong E
Brain Inj; 2016; 30(2):156-8. PubMed ID: 26619246
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of levetiracetam in neurosurgical ICU patients.
Ong CLJ; Goh PSJ; Teo MM; Lim TP; Goh KKK; Ang XY; Lim LJK; Jamaludin NHB; Ang BT; Kwa LHA
J Crit Care; 2021 Aug; 64():255-261. PubMed ID: 34051579
[TBL] [Abstract][Full Text] [Related]
14. Select critically ill patients at risk of augmented renal clearance: experience in a Malaysian intensive care unit.
Adnan S; Ratnam S; Kumar S; Paterson D; Lipman J; Roberts J; Udy AA
Anaesth Intensive Care; 2014 Nov; 42(6):715-22. PubMed ID: 25342403
[TBL] [Abstract][Full Text] [Related]
15. Impact of anti-epileptic drug choice on discharge in acute traumatic brain injury patients.
Harris L; Hateley S; Tsang KT; Wilson M; Seemungal BM
J Neurol; 2020 Jun; 267(6):1774-1779. PubMed ID: 32130500
[TBL] [Abstract][Full Text] [Related]
16. Levetiracetam Versus Phenytoin for Seizure Prophylaxis Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis.
Yang Y; Zheng F; Xu X; Wang X
CNS Drugs; 2016 Aug; 30(8):677-88. PubMed ID: 27395404
[TBL] [Abstract][Full Text] [Related]
17. Augmented Renal Clearance in Traumatic Brain Injury: A Single-Center Observational Study of Atrial Natriuretic Peptide, Cardiac Output, and Creatinine Clearance.
Udy AA; Jarrett P; Lassig-Smith M; Stuart J; Starr T; Dunlop R; Deans R; Roberts JA; Senthuran S; Boots R; Bisht K; Bulmer AC; Lipman J
J Neurotrauma; 2017 Jan; 34(1):137-144. PubMed ID: 27302851
[TBL] [Abstract][Full Text] [Related]
18. Augmented Renal Clearance Following Traumatic Injury in Critically Ill Patients Requiring Nutrition Therapy.
Dickerson RN; Crawford CN; Tsiu MK; Bujanowski CE; Van Matre ET; Swanson JM; Filiberto DM; Minard G
Nutrients; 2021 May; 13(5):. PubMed ID: 34063391
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam dosing for seizure prophylaxis in neurocritical care patients.
Hedges A; Findlay MC; Davis GE; Wolfe BM; Hawryluk GWJ; Menacho ST; Ansari S
Brain Inj; 2023 Aug; 37(10):1167-1172. PubMed ID: 36856437
[TBL] [Abstract][Full Text] [Related]
20. Incidence of neurobehavioral side effects associated with levetiracetam compared to phenytoin in traumatic brain injury patients.
Nguyen JV; Yaw T; Gratton H
Brain Inj; 2021 Jul; 35(8):902-906. PubMed ID: 34027761
[No Abstract] [Full Text] [Related]
[Next] [New Search]
